Narendra Dereddy, MD, was appointed to the Board of Directors of the Florida Birth-Related Neurological Injury Compensation Association (NICA) and will serve as the Florida representative of hospitals.
Dereddy currently serves as the medical director for neonatology, the neonatal intensive care unit, and pediatric care transformation at AdventHealth.
Created by Florida legislature in response to the malpractice insurance crisis where obstetricians were reluctant to treat high risk pregnancies, NICA is responsible for providing medically necessary help to infants affected by catastrophic birth-related neurologic injuries. The statutory organization manages state funds collected from participating physicians and hospitals to provide appropriate medical care and assistance to these infants and their families.
“As a neonatal-perinatal medicine specialist, I have cared for hundreds of infants affected by various birth related neurologic injuries and wanted to serve on the NICA board to advocate for these vulnerable infants and support preventive measures to decrease the incidence of birth-related neurologic injuries,” Dereddy said.
Dereddy attended medical school at Banaras Hindu University in India and completed his residency and fellowship at Maria Fareri Children’s Hospital at Westchester Medical Center at New York Medical College. Additionally, he is a member of the American Academy of Pediatrics.
Dereddy is one of several AdventHealth clinical leaders who have been recently appointed to a statewide post. He will serve in this position through August 2024.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
Blog
Myocardial Recovery is Possible After LVAD Implantation for Heart Failure
AdventHealth is the first Florida hospital to join the Myocardial Recovery International Network, a consortium exploring LVAD-mediated myocardial recovery.
News
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
News
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
News
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
Blog
Forging New Frontiers in Telesurgery to Improve Global Health Access, Outcomes and Equity
In our latest Clinician’s View, Dr. Patel shares his team’s journey toward improving global health access, outcomes and equity through telesurgery, including how they are ensuring the safety, quality...
Blog
Surgical Resection of Rare Pediatric Desmoid Jaw Tumor Optimizes Outcome and Helps Patient Avoid Chemotherapy
In our latest clinician’s view, Dr. Lopez shares how he, along with a multidisciplinary clinical team, were able to plan for this complex case and completely remove the tumor surgically, allowing...
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
Blog
New Treatments for Cardiac Amyloidosis Emerging, but Timely Diagnosis Remains Essential to Improving Outcomes
In our latest Clinician’s View, Marcos Hazday, MD, FACC, director of the hypertrophic cardiomyopathy program at AdventHealth Orlando, discusses the new cardiac amyloidosis therapeutics available...
Blog
Transforming Care for Patients with Inflammatory Bowel Disease Through a Dedicated, Interdisciplinary Specialty Clinic
In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...